National Neuroepidemiological Study in Colombia (EPINEURO);Estudio Neuroepidemiológico Nacional (EPINEURO) Colombiano

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 14, Issue 2, 2003, Pages 104-111

  Gustavo Pradilla, A ^a   Boris E Vesga, A ^a,b   León Sarmiento, Fidias E ^a,c   Roselli, Diego A ^d   Bautista, Leonelo E ^d   Morillo, Luis ^d   Uribe, Carlos S ^d   Takeuchi, Yuri ^d   Daza, Jorge ^d   Espinoza, Eugenia ^d   Camacho, Manuel I ^d   Pardo, Carlos A ^d  

^a UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

^b UNIVERSIDAD AUTÓNOMA DE BUCARAMANGA   (Colombia)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d Building 10 ^*

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE PREVALENCE; EPIDEMIOLOGY; HEALTH SURVEY; NEUROLOGY;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN INJURY; CEREBROVASCULAR DISEASE; CHILD; COLOMBIA; DEMENTIA; DEVELOPMENTAL DISORDER; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NEUROLOGIC DISEASE; NEUROLOGICAL COMPLICATION; NEUROPSYCHOLOGY; PARKINSON DISEASE; PERIPHERAL NEUROPATHY; PREVALENCE; PSYCHIATRIC DIAGNOSIS; SCHOOL CHILD; SEX DIFFERENCE;

EID: 0041416341     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1020-49892003000700005     Document Type: Article

References (54)

1. Pradilla G, Puentes F, Pardo C. Estudio neuroepidemiológico piloto. Acta Neurol Colomb 1984;8:133-139.
2. Alfonso H, León-Sarmiento FE, Brokate AM, Valderrama V, Parra JE. Epidemiología del SIDA basada en la evidencia. En: León-Sarmiento FE, ed. VIH y los virus de la imaginación humana. Santa Fe de Bogotá: Celsus; 2001. Pp. 13-32.
3. Schoenberg BS. Clinical neuroepidemiology in developing countries. Neuroepidemiology 1982;1:136-142.
4. Pradilla G, Pardo CA, Zúñiga A, Daza JS. Estudios neuroepidemiológicos colombianos empleando el protocolo de la OMS. Rev Neurol Arg 1994;19:9-14.
5. World Health Organization. Research protocol for measuring the prevalence of neurological disorders in developing countries. Geneva: World Health Organization, Neurosciences Program; 1981.
6. León-Sarmiento FE, Pradilla G, Pardo CA, Puentes F. The first neuroepidemiological study performed in Colombia using the World Health Organization protocol. Neurosciences (Tokyo) 1993;19:127-130.
7. Pradilla G, Vesga E, Sánchez LH. Estudio neuroepidemioló gico y toxicológico de una población minera con exposición crónica al mercurio. Acta Med Colomb 1992;17:322.
8. Pradilla G, Vesga E, Sánchez LH. Estudio neuroepidemioló gico y neurotoxicológico de plaguicidas en una zona algodonera del Sur del César, Colombia. Acta Med Colomb 1992;17:324.
9. Daza B, Caiaffa RH, Arteta BJ. Estudio neuroepidemiológico en Juan de Acosta, Atlántico, Colombia. Acta Med Colomb 1992;17:324.
10. Pradilla G, Vesga BE, León-Sarmiento FE. Estudio neuroepidemiológico en Aratoca: un área rural del oriente colombiano. Rev Med Chile 2002;130:191-199.
11. Pradilla G, Vesga BE, León-Sarmiento FE, Bautista LE, Núñez LC, Vesga E, et al. Neuroepidemiología en el oriente colombiano. Rev Neurol 2002;34:1035-1043.
12. Takeuchi Y, Guevara JG. Prevalencia de las enfermedades neurológicas en el Valle del Cauca. Colomb Med 1999;30:74-81.
13. Pradilla G, Roselli D, Bautista L, Morillo L, Uribe CS, Takeuchi Y, et al. Neuroepidemiología en Colombia. Acta Med Colomb 1998;23:258.
14. León-Sarmiento FE, Pradilla G, Villamil L, Vesga BE, Dallos M. Análisis crítico del mini-mental: 1975-1995. Acta Neurol Colomb 1999;15:135-145.
15. Chui HC, Victoroff JI, Margolin D. Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's Disease Diagnosis and Treatment Centers. Neurology 1992;42:473-480.
16. Yesavage JA. Geriatric depression scale. Psychopharmacol Bull 1988;24:709-711.
17. Blessed G, Tomlinson BE, Roth M. Blessed-roth dementia scale. Psychopharmacol Bull 1988;24:705-708.
18. Berg L. Clinical Dementia Rating (CDR). Psychopharmacology Bull 1988;24:637-639.
19. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
20. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, García JH. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
21. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, D.C.: American Psychiatric Association; 1994.
22. Departamento Administrativo Nacional de Estadística. Censo de población y vivienda 1993. Proyecciones de población para 1995. Santa Fe de Bogotá: DANE; 1995.
23. Kraus JF, McArthur DL. Epidemiological aspects of brain injury. Neurol Clin 1996;14:435-450.
24. Esteve J, Benhamou E, Raymond L. Descriptive epidemiology. Lyon: IARC Scientific Publications; 1994. (IARC Scientific Publications No. 128).
25. León-Sarmiento FE, Martínez M, García I. Migraña y calidad de vida en trabajadores hospitalarios colombianos, usando los protocolos de la OMS y MIDAS (MIDASELA), en español. Rev Neurol 2003;36:412-417.
26. Pradilla G, León-Sarmiento FE. Migraine prevalence. Neurology 1995;45:1030.
27. Silberstein SD, Lipton RB. Headache epidemiology: emphasis on migraine. Neurol Clin 1996;14:421-434.
28. Cruz ME. Estudio neuroepidemiológico en el Ecuador. Quito: CIEN, Fundación Eugenio Espejo, Ministerio de Salud Pública; 1984.
29. Osuntokun BO, Schoenberg BS, Nottidge V, Adeuja A, Kale O, Adeyefa A, et al. Migraine headache in a rural community in Nigeria: results of a pilot study. Neuroepidemiology 1982;1:31-39.
30. Ponce PL. Estudios neuroepidemiológicos en Venezuela. Caracas: Departamento de Enfermedades Neurológicas, Ministerio de Sanidad y Asistencia Social; 1985.
31. Cruz Gutiérrez del Olmo A, Schoenberg BS, Portera-Sánchez A. Prevalence of neurological diseases in Madrid, Spain. Neuroepidemiology 1989;8:43-47.
32. Zhao F, Tasy JY, Cheng X, Wong W, Li S, Yao S, et al. Epidemiology of migraine: a survey in 21 provinces of the People's Republic of China, 1985. Headache 1988;28:558-565.
33. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence: a review of population-based studies. Neurology 1994;44(Suppl 4):17-23.
34. Ziegler DK. Epidemiology of migraine. En: Anderson DW, ed. Neuroepidemiology: a tribute to Bruce Schoenberg. Boca Raton: CRC Press; 1991. Pp. 167-192.
35. Stein Z, Durkin M. Serious mental retardation in developing countries: an epidemiologic approach. Ann NY Acad Sci 1986;477:8-21.
36. León-Sarmiento FE, de Castro Costa CM, Gaffga N. Discrepancy, coincidence or evidence in chronic idiopathic spastic paraparesis throughout the world. Arq Neuropsiquiat 1997;55(3B):530-535.
37. Rocca WA, Amaducci L. Epidemiology of Alzheimer's disease. In: Anderson DW, ed. Neuroepidemiology: a tribute to Bruce Schoenberg. Boca Raton: CRC Press; 1991. Pp. 55-96.
38. López S, Llinás J, Vilalta J, Lozano L. The prevalence of dementia in Girona. Neurología 1995;10:189-193.
39. Pi J, Olivé JM, Roca J, Masana L. Prevalence of dementia in a semi-rural population of Catalunya, Spain. Neuroepidemiology 1996;15:33-41.
40. Munoz M, Boutros-Toni F, Preux PM, Chartier JP, Ndzanga E, Boa F. Prevalence of neurological disorders in Haute-Vienne department (Limousin region-France). Neuroepidemiology 1995;14:193-198.
41. Sanders JWAS, Shorvon SD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry 1996;61:433-443.
42. Reggio A, Failla G, Patti F, Nicoletti A, Grigoletto F, Meneghini F. Prevalence of epilepsy. A door-to-door survey in the Sicilian community of Riposto. Ital J Neurol Sci 1996;17:147-151.
43. Vesga BE. Neuroepidemiología de la epilepsia. Salud UIS 2001;33:229-235.
44. Cockerell OC, Eckle I, Goodridge DM, Sander JW, Shorvon SD. Epilepsy in a population of 6.000 re-examined: secular trends in first attendance rates, prevalence, and prognosis. J Neurol Neurosurg Psychiatry 1995;58:570-576.
45. Pradilla G, León-Sarmiento FE, Gamarra G. Síndrome de Guillain-Barre en el oriente colombiano. Acta Neurol Colomb 1999;15:14-23.
46. Bharucha NE, Bharucha AE, Bharucha EP. Prevalence of peripheral neuropathy in the Parsi community of Bombay. Neurology 1991;41:1315-1317.
47. Beghi E, Monicelli ML, Amoruso L, Apollo F, Delodovivi ML, Grampa G. Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. Prevalence and general characteristics of the sample. Neurology 1995;45:1832-1836.
48. Jennett B. Epidemiology of head injury. J Neurol Neurosurg Psychiat 1996;60:362-369.
49. Uribe CS, Jiménez I, Mora MO, Arana A, Sánchez JL, Zuluaga L. Epidemiología de las enfermedades cerebrovasculares en Sabaneta, Colombia (1992-1993). Rev Neurol 1997;25:1008-1012.
50. Davis PH, Hachinski V. Epidemiology of cerebrovascular disease. In: Anderson DW, ed. Neuroepidemiology: a tribute to Bruce Schoenberg. Boca Raton: CRC Press; 1991. Pp. 27-53.
51. León-Sarmiento FE, Mendoza E, Prada J, Silva CA, Vera SJ, Castillo E. Enfermedad cerebrovascular y Trypanosoma cruzi en el oriente colombiano. Acta Neurol Colomb 2001;17:171-177.
52. León-Sarmiento FE, Mendoza E, Torres-Hillera M. Trypanosoma cruzi-associated cerebrovascular disease: A case-control study at Eastern Colombia. J Neurol Sci (en prensa).
53. Pinto NX, Torres-Hillera M, Mendoza E, León-Sarmiento FE. Immune response, nitric oxide, autonomic dysfunction and stroke: a puzzling linkage on T. cruzi infection. Med Hypoth 58:374-377.
54. Zhang Z, Román GC. Worldwide occurrence of Parkinson's disease: an updated review. Neuroepidemiology 1993;12:195-208.